Literature DB >> 33553021

Investigating the demographic characteristics and pathological manifestations of thyroid Cancer during the last two decades (1997-2017) in patients referred to Baqiyatallah hospital, Tehran, Iran.

Majid Ramezani1, Masoumeh Saeidi2, Ali Zarei3, Mahmoud Hasani1.   

Abstract

BACKGROUND &
OBJECTIVE: Thyroid cancer is among the most common endocrine cancers, and its incidence in our country is in progress over the past decades. This aggravates the necessity to evaluate the changes in thyroid cancer. MATERIALS &
METHODS: Through accessing the information of the records of all patients with a diagnosis of thyroid cancer between 1996 and 2017, the present study was conducted at Baqiyatallah Hospital (Tehran, Iran) according to scientific criteria. After the diagnosis, most of them also underwent surgery and were evaluated in terms of the rate of the involvement and the type of thyroid cancer, and the pathology report was recorded in their records. Information about the intended patients such as age, gender, pathologic type of cancer, associated with the patient (except thyroid cancer), and history of radiation to the patient were recorded in a standard form and subjected to statistical analysis. Demographic changes and pathological manifestations of cancers in the two decades (1997-2007) and (2007-2017) were compared. But comparisons have been made over five years.
RESULTS: The incidence of thyroid cancer, especially papillary thyroid cancer type, was increasing at an early age, and the incidence of tumor size measuring 2-4 cm was rising. But the incidence of tumor sizes less than one centimeter declined. The amount of vascular and capsule involvement was about 3 times, and lymph node involvement was nearly 2 times. The increasing incidence of 2-4 cm tumor size in the age group of 20-50 years was more than other age groups.
CONCLUSION: The incidence of thyroid cancer was increasing at an early age, and the enhancement of papillary thyroid type was higher than other types. As well as, in this study, it was found that the incidence of 2-4 cm tumor sizes was rising. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Demographic; Hospital; Pathologic; Thyroid Cancer

Year:  2020        PMID: 33553021      PMCID: PMC7843909          DOI: 10.1007/s40200-020-00617-x

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  19 in total

1.  Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours.

Authors:  Juan P Brito; John C Morris; Victor M Montori
Journal:  BMJ       Date:  2013-08-27

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification.

Authors:  Iain J Nixon; Ian Ganly; Snehal G Patel; Frank L Palmer; Monica M Di Lorenzo; Ravinder K Grewal; Steven M Larson; R Michael Tuttle; Ashok Shaha; Jatin P Shah
Journal:  Thyroid       Date:  2013-06       Impact factor: 6.568

4.  Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.

Authors:  L Dal Maso; A Tavilla; F Pacini; D Serraino; B A C van Dijk; M D Chirlaque; R Capocaccia; N Larrañaga; M Colonna; D Agius; E Ardanaz; J Rubió-Casadevall; A Kowalska; S Virdone; S Mallone; H Amash; R De Angelis
Journal:  Eur J Cancer       Date:  2017-04-11       Impact factor: 9.162

5.  Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.

Authors:  Amy Y Chen; Ahmedin Jemal; Elizabeth M Ward
Journal:  Cancer       Date:  2009-08-15       Impact factor: 6.860

6.  Current thyroid cancer trends in the United States.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-04       Impact factor: 6.223

7.  Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.

Authors:  Reza Asari; Oskar Koperek; Christian Scheuba; Philipp Riss; Klaus Kaserer; Martha Hoffmann; Bruno Niederle
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

8.  Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.

Authors:  Lindsey Enewold; Kangmin Zhu; Elaine Ron; Aizen J Marrogi; Alexander Stojadinovic; George E Peoples; Susan S Devesa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

9.  The increasing incidence of thyroid cancer: the influence of access to care.

Authors:  Luc G T Morris; Andrew G Sikora; Tor D Tosteson; Louise Davies
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

10.  Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.

Authors:  Gabriella Pellegriti; Francesco Frasca; Concetto Regalbuto; Sebastiano Squatrito; Riccardo Vigneri
Journal:  J Cancer Epidemiol       Date:  2013-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.